SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Mostrar otras versiones (1)

Correction to: British Journal of Cancer (2002) 87, 630–634. doi:10.1038/sj.bjc.6600511

Detalles Bibliográficos
Autores principales: Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394240/
http://dx.doi.org/10.1038/sj.bjc.6601020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394240/
http://dx.doi.org/10.1038/sj.bjc.6601020

Ejemplares similares